Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 8

1.

Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer.

Wu X, Burden-Gulley SM, Yu GP, Tan M, Lindner D, Brady-Kalnay SM, Lu ZR.

Bioconjug Chem. 2012 Aug 15;23(8):1548-56. doi: 10.1021/bc300009t. Epub 2012 Aug 1.

2.

A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.

Ye F, Wu X, Jeong EK, Jia Z, Yang T, Parker D, Lu ZR.

Bioconjug Chem. 2008 Dec;19(12):2300-3. doi: 10.1021/bc800211r. Erratum in: Bioconjug Chem. 2009 Feb 18;20(2):402. Wu, Xueming [added].

3.

Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds.

Pilch J, Brown DM, Komatsu M, Järvinen TA, Yang M, Peters D, Hoffman RM, Ruoslahti E.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2800-4. Epub 2006 Feb 13.

4.

Functional structure and composition of the extracellular matrix.

Bosman FT, Stamenkovic I.

J Pathol. 2003 Jul;200(4):423-8. Review.

PMID:
12845610
5.

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Wang YX, Hussain SM, Krestin GP.

Eur Radiol. 2001;11(11):2319-31. Review.

PMID:
11702180
6.

Molecular and cellular basis of cancer invasion and metastasis: implications for treatment.

Jiang WG, Puntis MC, Hallett MB.

Br J Surg. 1994 Nov;81(11):1576-90. Review.

PMID:
7827878
7.

Future directions in magnetic resonance contrast media.

Runge VM, Gelblum DY.

Top Magn Reson Imaging. 1991 Mar;3(2):85-97. Review.

PMID:
2025435
8.

New directions in the development of MR imaging contrast media.

Brasch RC.

Radiology. 1992 Apr;183(1):1-11. Review.

PMID:
1549653

Supplemental Content

Support Center